Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
CTCX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.22
+346%
0.03
vs -0.01
Q1.23
N/A
NA
vs -0.03
Q2.23
N/A
-0.62
vs -0.02
Q3.23
N/A
-0.62
vs -0.32
Q4.23
+883%
0.29
vs 0.03
Q1.24
N/A
-0.16
vs NA
Q2.24
N/A
-0.16
vs -0.62
Q3.24
N/A
-0.14
vs -0.62
Q4.24
N/A
NA
vs 0.29
Q1.25
N/A
NA
vs -0.16
Sales Growth
YoY
Current
Estimates
Q4.22
NA
NA vs NA
Q1.23
NA
NA vs NA
Q2.23
NA
NA vs NA
Q3.23
NA
3.7M vs NA
Q4.23
NA
-3728816.00 vs NA
Q1.24
NA
NA vs NA
Q2.24
NA
12.3K vs NA
Q3.24
-99%
20.5K vs 3.7M
Q4.24
+100%
17.5K vs -3728816
Q1.25
NA
510.4K vs NA
Return on Equity
QoQ
Q1.23
+0%
0
vs 0.08
Q2.23
+0%
0
vs 0
Q3.23
-55%
-0.55
vs 0
Q4.23
+13%
0.13
vs -0.55
Q1.24
+345%
3.45
vs 0.13
Q2.24
+241%
2.41
vs 3.45
Q3.24
+71%
0.71
vs 2.41
Q4.24
+19%
0.19
vs 0.71
Institutionnal Ownership
globenewswire.com
8 hours ago
globenewswire.com
8 hours ago
globenewswire.com
8 hours ago
globenewswire.com
8 hours ago
Quote Panel
Key Metrics
Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
NASDAQ
Unprofitable
EPS improving
Unprofitable
EPS improving
0.00 ( 1.39%)
Relative Strenght
3
Volume Buzz
-99%
Earning Acce
No
Dist 52w H.
93%Relative Strength
CTCX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How CTCX compares to sector?
CTCX
-4x